Dipen A. Patel, BPharm, PhD

Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions

Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health

FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors

FLT3 Inhibitor Gilteritinib May Also Be Effective as ALK Inhibitor in AML

Patients With MDS Disagree With Physicians About Symptom Frequency

Maternal Deaths, and Disparities, Become a Grassroots Cause